Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
H
Hisamitsu Pharmaceutical Co Inc
F:HPX
Hisamitsu Pharmaceutical Co Inc
F:HPX
Price:
31.8
EUR
Market Cap:
€2.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently viewed
Price
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HPX's stock price target?
Not Available
HPX does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Hisamitsu Pharmaceutical Co Inc?
Projected CAGR
4%
4%
Over the last 14 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 3 years is 4%.
What is the Gross Profit forecast for Hisamitsu Pharmaceutical Co Inc?
Projected CAGR
2%
2%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 3 years is 2%.
What is the Operating Income forecast for Hisamitsu Pharmaceutical Co Inc?
Projected CAGR
-2%
-2%
Over the last 14 years, the compound annual growth rate for Operating Income has been -3%. The projected CAGR for the next -14 years is -2%.
What is the Pre-Tax Income forecast for Hisamitsu Pharmaceutical Co Inc?
Projected CAGR
3%
3%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been -2%. The projected CAGR for the next 3 years is 3%.
What is the Net Income forecast for Hisamitsu Pharmaceutical Co Inc?
Projected CAGR
-1%
-1%
Over the last 14 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 3 years is -1%.